FindMyKOL
Clinical trialNCT07296770Not, yet, recruitingPhase 3Interventional

An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service

NCT07296770 is a phase 3 interventional trial sponsored by University of California, San Francisco. As of 18 Nov 2026, it is not yet recruiting. It studies Pharmacologic Pain Management in Opioid Use After Surgery, Postsurgical Pain Management and 1 more condition. The registry lists an enrollment of 474 participants at 1 site in 1 country. The registry lists a start date of 1 Oct 2026 and a primary completion date of 1 Dec 2028.

SponsorUniversity of California, San Francisco →Enrollment474Opioid Use After SurgeryPostsurgical Pain ManagementPostsurgical Pain, Chronic
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT07296770
FieldValue
Registry IDNCT07296770
StatusNot yet recruiting
PhasePhase 3
Study typeInterventional trial
Lead sponsorUniversity of California, San Francisco
Enrollment474
Registered sites1
Countries1
ConditionsOpioid Use After Surgery, Postsurgical Pain Management and Postsurgical Pain, Chronic
DrugsPharmacologic Pain Management
Start1 Oct 2026
Primary completion1 Dec 2028
Study completion1 Dec 2029
Last update posted9 Oct 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to learn whether a pain-management program called a Transitional Pain Service can help prevent long-term pain and reduce opioid needs after surgery in adult surgical patients who may be at higher risk for developing persistent pain. The main questions this trial aims to answer are: 1) Does the Transitional Pain Service help high-risk surgical patients manage pain better after surgery? 2) Can a computer tool (an algorithm) improve screening of patients for long-lasting pain after surgery? The investigators will compare patients who continue with their usual care to patients who receive support from the Transitional Pain Service to see if the program leads to better pain control and lower opioid use. Participants will share information about their pain levels and the pain-relief treatments they are using before and after surgery so researchers can better understand how the program affects recovery. Patients assigned to the Transitional Pain Service will also be offered additional coordinated support before and after their surgery to help optimize their pain control and overall recovery.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • Ucsf Hospitals

    San Francisco

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Pharmacologic Pain Management
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT07296770

Each answer restates registry values shown on this page.

What is NCT07296770?

NCT07296770 is a phase 3 interventional trial sponsored by University of California, San Francisco. It studies Pharmacologic Pain Management in Opioid Use After Surgery, Postsurgical Pain Management and 1 more condition.

Is NCT07296770 recruiting?

As of 18 Nov 2026, it is not yet recruiting.

Who leads NCT07296770?

The registry names Andrew Bishara, MD (principal investigator, UCSF Department of Anesthesia) as the overall official.

Where does NCT07296770 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT07296770 study?

The registered drug and biological interventions are Pharmacologic Pain Management.

When is NCT07296770 expected to complete?

The registry lists a primary completion date of 1 Dec 2028 and a study completion date of 1 Dec 2029. The sponsor last updated the record on 9 Oct 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.